Drugs / BMEC-1217B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00425971 | Jul 2008 → ? | asthma | Medigreen Biotechnology Corp. | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMEC-1217B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00425971 ↗ |
| Action | Inhibit | “BMEC-1217B can inhibit the synthesis of several key pro-inflammatory mediators involved in the pathophysiology of allergic asthma” NCT00425971 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “BMEC-1217B is an abbreviated version of an old Chinese formulation.” NCT00425971 ↗ |
| Route | Oral | “when administered orally” NCT00425971 ↗ |